drugset / Trial / NCT02213783
Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
RandomizedParallel-groupOpen-labelTreatment
Summary
This is prospective and randomized study to compare the pharmacodynamics (t\>MIC) of 0.5 g every 6 h of imipenem in twelve patients with febrile neutropenia following administration by a 4 h infusion or bolus injection. Concentration of imipenem in plasma will be measured by HPLC method and simulated in Monte Carlo technique (Computer model) to get PK/PD index (40%T\>MIC) and reported to %PTA (Probability Target Attainment) and %CFR (Cumulative Faction Response.
Timeline
- Start
- 2011-02
- Primary completion
- 2013-07
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMIPENEM ANHYDROUS | Small molecule | 0.5 g | — |
Indications
No indication recorded.